360 Pediatric Phototherapy References

1. Pearson HA: Life-span of the fetal red blood cell, I PEDIATR, 1967; 154-5.
2. Schmid RD, Diamond 1, Hammaker L, CB: Interaction of bilirubin with albumin, NATURE, 1965; 206:1041.
3. With T: Bile Pigments, New York: Academic Irress, 1968).
4. Lightner D. McDonagh A: Molecular mechanisms of phototherapy for neonatal jaundice, ACCOUNTS CHEM RES, 1984; 17:417-24.
5. Ostrea EM, Ontengro EA, Tolia VA, Apostol B: The occurrence and significance of the bilirubin species including delta bilirubin in jaundiced infants, I PED GASTROENTEROL
NUTR, 88 Jul-Aug; 7(4):51 1-6.
6. Wu TW: Bilirubin analysis – the state of the art and future prospects, CUN BIOCIIEM, 1984 Aug; 17(4):221-9.
7. Brett EM,Hicks JM, Powers DM, Rand RN: Delta bilirubin in a serum of pediatric patients: correlations with age and disease, CLIN CHEM, 19g4 Sep. 30(9)1561-4.
8. Weiss 35, Guatam A, Lauff 33, Sundberg MW, Ct al: The clinical importance of a protein-bound fraction of serum bilirubin in patients with hyperbilirubinemia, N ENG I MED,
1983 Jul 21; 309(3):147-50.
9. Rutiedge IC, Cu CN: Bilirubin & the laboratory. Advances in ths 1980s, considerations for the 1990s, PED CLIN N AM, 1989 Feb; 36c1):189-98.
10. Murals M, Rubaltelli EF, Blanekaert N, Fevery 3: Unconjugated & conjugated bilirubin pigments during perinatal development, BIOL NEONATE, 1990; 57(l):l-9.
11. Maisela MI, Gifford K, Antle CE, Leib GR: Jaundice in the healthy newborn infant: a new approach to an old problem, PEDS, 1988 Apr; 81(4):505-ll.
12. Moutosin JM, Gagnon R, Rainville C, Giroux L, Ct al: Maternal & neonatal outcome in pregnancies with no risk factors, CAN MED ASSOC 3.1987 Oct 15; 137(8):728-32.
13. Eidelmsn Al, Schirrsner MS: Phototherspy 1988. A green light for a new approach, I PERINATOL, 1989 Mar; 9(l):69-71.
14. Linn S, Schoenbaum SC, Monson RR, Rosner B, et al: Epidemiology of neonatal hyperbilirubinemia, PEDS, 1985 Apr; 75(4):770-4.
15. Tenovua A: Neonatal complications in small-for-gestational age neonates, 3 PERINAT MED, 1988; 16(3):197.203.
16. Cashore WI, Stem L: The management of hyperbilirubinemia, CLIN PERINATOL, 1984 Jun; 11 (2):339-57.
17. Chen SH, Lee TC: Carboxyhemoglobin and glucuronide formation in Chinese newborn infants with hyperbilirubinemia, TAIWAN I HSUEH HUI TSA CHIH, 1980 Mar;
79(3):314-22.
18. Ebbeson F, Broderson R: Risk of bilirubin acid precipitation in preterm infants with respiratory distress syndrome: considerations of blood/brain bilirubin transfer equilibrium,
EARLY HUM DEVEL, 1982 Sep, 6(4):341-55.
19. Linder N, Arad 1: Plasma haptoglobin levels in vacuum extracted neonates, I PERINAT MED, 1984; 12(l):35.7.
20. Bansal A, Bothra GC, Venna CR: Hyperbilirubinemia due to massive cephalohematoma, INDIAN PEDIATR, 1985 Aug; 22(8):619-21,
21. Arad I, Fainmesser P, Birkenfeld A, Oulaiev B, Sadovaky B: Vacuum extraction and neonatal jaundice, I PERINAT MED, 1982; 10(6):273.8.
22. Dunn PA, Bhutan V, Weiner S, Ludomiraki A: Care of the neonate with erythroblastosia fetalis, 3 OBST GYN NEONAT NURS, 1988 Nov-Dec; 17(6):382-6.
23. Zipuraky A: Mechanisms of hemolysis, MEAD JOHNSON SYMP PERINAT DEV MED, 1982; (19):17.24.
24. Orralesi M, Gloria-Bottini F, Lucarelli P, Lucarini N, Ct al: ABO system incompatibility: evaluation of risk of hyperbilirubinemia at birth by multivariate discriminant analysis.
EXPERIENTIA, 1983 Ian; 39(l):89-91.
25. Senran PA, Modanlov HI): Significance of anti-A and anti-B isohemoglutinins in cord blood of ABO incompatible newborn infants: correlation with hyperbilirubinemia, 3 PERINATOL,
1989 Jun; 9(2):154-8.
26. Kanto WP, Marino B, Godwin AS. Bunyapen C: ABO hemolytic disease: a comparative study of clinical severity and delayed anemia, PEDIATRICS, 1978 Sep; 62(3):365-9.
27. Sivan Y, Merlob P, Nutman 3, Reisner SH: Direct hyperbilirubinemia complicating ABO hemolytic disease of the newborn, CLIN PEDIATR (PIIILA), 1983 Aug; 22(8):537-8.
28. Kats MA, Kanto WP, Korotkin JH: Recurrence rate of ABO hemolytic disease of the newborn, OBSTET GYNECOL, 1982 May; 59(5):611A.
29. Plotz RD: Familial occurrence of hemolytic disease of the newborn due to AO blood group incompatibility, HUM PATHOL, 1985 Feb; 16(2):113-6.
30. Caine ME, Mueller-Heubach B: Kell sensitization in pregnancy, AM 3 GB GYN, 1986 Jan; 154(l):85-90.
31. Wolkoff AW: Inheritable disorders manifested by conjugated hyperbilirubinemia, SEMIN LIVER DIS, 1983 Feb; 3(l):52-64.
32. Calabrese El: High neonatal plasma ascorbic acid levels as a contributing cause of hyperbilirubinemia amongst G-6-PD deficient infants, MED HYPOTHESES, 1982 Sep;
9(3):311-2.
33. Meloni T. Erre S, Gallisai D, Cutlilo S: Beta-thalassemia trait and hyperbilirubinemia in G-6-PD deficient newborn infants, BURl PEDIATR, 1980 Aug; 134(2):1 19-20.
34. Tan KL, Loganath A. Roy AC, Goh HH, et al: Cord plasma alpha-fetoprotein values and neonatal jaundice, PEDIATRICS, 1984 Dec; 74(6):1065-8.
35. Han AT, Balakrishnan S, Ahrnad Z: Hyperbilirubinemia and erythrocyte G-6-PD deficiency in Malaysian children, MED I MALAYSIA, 1989 Mar; 44(l):30-4.
36. Schroter W, Kashnitz E: Diagnosis of hereditary apherocytosis in newborn infants, I PEDIATR, 1983 Sep; 103(3):460-3.
37. Maxwell DI, Seshadri R, Rumpf DI, Miller IM: Infantile pyknocytosis: a cause of intrauterine hemolysis in 2 siblings, AUST N Z I OBSTET GYNAECOL, 1983 Aug; 23(3):182-
5.
38. Baker 3W, Hamison KL, Harvey P1: Anti-C hemolytic disease requiring intrauterine and exchange transfusion, MED I AUST, 1981 Sep 19; 2(6):296.
39. Beutier E, Dunning D, Dabe lB, Furman L: Erytitrecyte glutathione 5-transferase deficiency & hemolytic anemia, BLOOD, 1988 Jul; 72(l):73-7.
40. Bracci R, Buonocore G, Talluri B, Berni S: Neonatal hyperbilirubinemia: evidence for a role of the erythrocyte enzyme activities involved in the detoxification of oxygen radicals,
ACTA PED SCAND, 1988 May; 77(3):349-56.
41. Lawe lB: Successful exchange transfusion of an infant for AIHA developing late in mother’s pregnancy. TRANSFUSION, 1982 Ian-Feb; 22(l):66-8.
42. Wisweil TE. Comish ID, Northam RS: Neonatal polycythemia: frequency of clinical manifestation and other associated findings, PEDIATRICS, 1986 Jun; 78(l):26-30.
43. Ballin A, Brown El. Koren G, Zipuraky A: Vitamin C-induced erythrocyte damage in premature infants, I PEDIATR, 1988 Jul; 113(1 pt l):114-20.
44. Opita IC, Baldauf MC, Kessler DL, Meyer IA: Hemolysis of blood in IV tubing caused by heat, I PEDIATR, 1988 Ian; 112(1):111-3.
45. Ouvrier RA: Advances in neonatal neurology, BRAIN DEV, 1984; 6(6):520-7.
46. Ballin A, Brown El, Zipursky A: Idiopathic Heinx body hemolytic anemia in newborn infants, AM I PED HEMATOL ONCOL, 1989 Spring; ll(l):3-7.
47. Menon PA, Thach BT, Smith CH, Landt M, Ct al: Benxyl alcohol toxicity in a neonatal intensive care unit. Incidence, symptomatology, and mortality, AM I PERINATOL, 1984
Jul; 1(4):288-92.
48. Hammer SG, Lewan RB: Neonatal hyperbilirubinemia caused by pyruvate kinase deficiency, 3 AM BRD F P, 1988 Oct-Dec; l(4):288-90.
49. Bloomer IR, Sharp HL: The liver in Crigler-Hajjar syndrome, protoporphyria, and other metabolic disorders, IIEPATOLOGY, 1984 Ian-Feb; 4(1 suppl):18S-21S.
50. Odievre M, Luzeau R, Alagille D: Prolonged neonatal jaundice: a manifestation of heterozygote state for Crigler-Najjar syndrome?, I PEDIATR GASTROENTEROL NUTR,
1982; l(2):239-41.
51. Wong HB: Pediatric liver disorders in Singapore, ANN ACAD MED SINGAPORE, 1986 Apr; 15(2):239-49.
52. Sinatra FR: Choleatasis in infancy & childhood, CUR PROBL PEDIATR, 1982 Oct; 12(12):l-54.
53. Ghishan EK, LaBrecque DR, Mitros FA, Younoszai MJK: The evolving nature of “infantile obstructive cholangiopathy”, I PEDIATR, 1980 Jul; 97(l):27-32.
54. Finni K, Sinnia S, Heikura S. lanne 0, Maentausta 0: Serum bile acid concentrations in the course of benign recurrent intrahepatic cholestasis, ANN CLIN RES, 1980 Aug;
12(4):168-71.
55. Whitley CB, Schwarzrnberg SI. Burke BA, Freese DK, Gorlin RI: Direct hyperbilirubinemia & hepatic fibrosis: a new presentation of Jeune syndrome, AM I MED GENET
SUPPL, 1987; 3:211-20.
56. Kahn E, Dawn F: Arteriohepatic dysplasia (Alagilic’s syndrome): a common cause of conjugated hyperbilirubinemia, ANN CLIN LAB Sd, 1984 Nov-Dec; l4(6):48O~6.
57. Mikati MA, Barakat AY, Sulh IlB, Der Kaloustian VM: Renal tubular insufficiency, choleatatic jaundice, and multiple congenital anomalies – a new multisystem syndrome, HELV
PAEDIATR ACTA, 1984 Dec; 39(5-6):463-71.
58. Tolis V, Dubola RS, Watta FB Jr, Perrin E: Renal abnormalities in paucity of interlobular bile ducts, 3 PED GASTROENTEROL NUTR, 1987 Nov-Dec; 6(6):971-6.
59. Chuang 3H, Chen MI: Membranous atresia of esophagus associated with pyloric stenosis, J PED SURG, 1987 Nov; 22(l1):988-90.
60. Ghiahan IK, Lallrecuue DR, Mitros FA, Younoazai MK: Pyloric stenosis and direct hyperbilirubinemia with alpha-1-antitrypain deficiency, CUN PEDIATR (PHILA), 1980 Apr;
19(4):293-5.
61. Rommen M, Singh MP: Pyloric duplication in a preterm neonate, 3 PEDIATR SURG, 1984 Apr; 19(2):158-9.
62. Banta EW: Vaiproic acid and congenital malformations. A case report, CUN PEDIATR (PHILA), 1984 Jun; 23(6):352-3.
63. Sivan Y, Mutman 3, Zeevi B, Berant M, Ct al: Acute hepatic failure after open heart surgery in chilren, PED CARDIOL, 1987; 8(2):127-30.
64. Procianoy RS, Giacomin CB, Mattoa TC, Recach LH: Congenital Wilma tumor associated with consumption coagulopathy and hyperbilirubinemia, 3 PED SURG, 1986 Nov,
21(l1):993-4.
65. BredskyL, Reidy M, Stanievich JF: The effects of auctioning techniques on the tracheal mucosa intubated low birth weight infants, INTJ PEDOTORHINOLARYNGOL, 1987
Nov; 14(l):l-14.
VII-1
66. Vaca G, Castro-Felix LP, Medina C, Medina MID, et al: Reduced levels of uridine diphosphate glucose phosphorylase activityin fetal and neonatal human and guinea pig liver.
BIOL NEONATH, 1989; 56(3):174-80.
67. Mslska-Zafiriu K, Koliouskas D, Konopoulos E, Danielides B, Cassimos C: Serum gamma-glutamyl transpeptidase, D-glucaric acid excretion and plasma half-life of antipyrine in
newborns with severe jaundice of unknown etiology and due to glucose-6.phosphate dehydrogenase deficiency in Greece, HELV PAEDIATR ACTA, 1981; 36(2):149-58.
68. Frishherg Y, Zelicovic I, Merlob P. Reisner SH: Hyperbilirubinemia and influencing factors in term infants, ISR 3 MED SCI, 1989 Jan; 25(l):28-31.
69. Johnson JD, Angelus P, Aldrich M, Saipper BJ: Exaggerated jaundice in Navaho neonates. The role of bilirubin production, AM 3 DIS CHIU), 1986 Sep; 140(9):889-90.
70. Posil BD, Nelson N. Carson 3: Hyperbilirubinemia in Inuit neonates, CAN MED ASSOC 3.1982 Apr; 126(7):8ll-3.
71. Leibson C, Brown M, Thibodeau S, Stevenson D, Ct al: Neonatal hyperbilirubinemia with high altitude, AM J DIS CIIIU), 1989 Aug; 143(8):983-7.
72. Moore LG. Newberry MA, Freeby GM, Crnic LS: Increased incidence of neonatal hyperbilirubinemia at 3100 m in Colorado, AM J DIS CIIILD, 1984 Feb; 138(2):157-61.
73. Khoury MI, Calie EE, Joesoef RM: Recurrence risk of hyperbilirubinemia in siblings, AM J DIS CHELD, 1988 Oct; 142(10):1065-9.
74. Syrop CH, Varner MW: Triplet gestation: maternal and neonatal implications. ACTA GENET MED GEMELLOL ROMA), 1985; 34(l-2):81-8.
75. Hertr JB, Heisterberg L: The outcome of pregnancy after threatmened abortion, ACTA OBSTET GYNECOL SCAND. 1985; 64(2).. 151-6.
76. Khatus SP, Achintys AS, Khatus S, Batabyal SK: Plasma lipids and blood glucose in infants of toxemic mothers, INDIAN 3 PEDS, 1989 May-Jun; 56(3):403-8.
77. McEnemey 3K, McEnerney LN: Unfavorable neonatal outcome after interamniotic injection of methylene blue, OBSTET GYNECOL, 1983 Mar; 61(3 Suppl):355-37S.
78. Johnson JD, Aldrich M, Angelus P, Stevenson DK, Ct al: Oxytocin and neonatal hyperbilirubinemia. Studies of bilirubin production, AM 3 DIS CHIU), 1984 Nov; 138(11):1047-
50.
79. Joupplis R, Larva L, Jouppila P, Koivisto M, Paltarinen A: Effects of segmental epidural analgesia on neonatal serum bilirubin concentration and incidence of neonatal hyperbilirubinemia,
ACTA OBSTET GYNECOL SCAND, 1983; 62(2):179-82.
80. Musci MN Jr, Abbas S, Otis C, Bolognese RI: Prolonged fetal ritodrine exposure and immediate neonatal outcome, 3 PERINATOL, 1988 Winter; 8(1):27-32.
81. Tei A, Oiyams H, Okaws S, Saito M: Clinical application of Hobel’s high-risk pregnancy screening system, BULL TOKYO MED DENT UNIV, 1989 Mar; 35(4):81-8.
82. Toth A, Lesser ML, Brooks-Toth CW, Feiner C: Outcome of subsequent pregnancies following antibiotic therapy after primary or multiple spontaneous abortions, SURO GYN
OB, 1986 Sep; 163(3):243-50.
83. Nemeth I, Szelecxki T, Beds D: Hyperbilirubinemia and urinary D-glucaric acid excretion in premature infants following antepartum dexamethasone treatment, J PERINAT MED,
1981; 9(l):35-9.
84. Rawat AK, Sharma A: Development of hepatic bilirubin glucuronidation as affected by prolonged maternal ethanol intake, ALCOHOL, 1986 Mar-Apr; 3(2):139-43.
85. Waffam F, Carlisle S, Pens I, Hodgmsn JE, Bonham D: Fetal exposure to maternal hyperbilirubinemia. Neonatal course and outcome, AM 3 DIS CHIU), 1982 May; 136(5):4167.
86. Cotton DB, Brock RI, Schifrin BS: Cirrhosis and fetal hyperbilirubinemia, OBSTET GYNECOL, 1981 Jun; 57(6 Suppl):255-75.
87. Cotton DB: Infantile hepatic cholestasis with maternal Dubin-Juinson syndrome, SOUTH MED 3, 1984 Sep; 77(9):229-33.
88. Muhibsuer B, Bems LM, Singer A: Congenital measles – 1982, ISR 3 MED SCI, 1983 Nov; 19(ll):987-8.
89. Stratton 3A, Miller RD, Schmidt P: Effect of maternal parasitic disease on the neonate, AM 3 REPROD IMMUNOL MICROBIOL, 1985 Aug; 8(4):141-2.
90. Reitano 0: Treatment of emergency cases in newborn infants of diabetic mothers, ACTA ENDOCRIN SUPPL (COPENH), 1986; 277:159-62.
91. Diamond Mp, Salyer SL, Vaughn WK, Cotton RB, Ct al: Continuing neonatal morbidity in infants of women with class A diabetes, SOUTH MED 3, 1984 Nov; 77(ll):13868,
1392.
92. Renade AY, Merchant RH, Bajaj RT, Joshi NC: Infants of diabetic mothers – an analysis of 50 cases, INDIAN PEDIATR, 1989 Apr; 26(4):366-70.
93. Hanson U, Perason B, Enochason E, Lennerhagen P, et 51: Self-monitoring of blood glucose by diabetic women during the third trimester of pregnancy, AM 3 OBSTET GYNECOL,
1984 Dec 1; 150(7):817-21.
94. Lin CK, Liu HC, Yau KI, Ct al: Clinical analysis of infants of diabetis mothers, ACTA PEDIATR SING, 1989 Jul-Aug; 30(4):233-9.
95. Monis MA, Grandis AS, Litton JC: Glycosylated hemoglobin concentration in early gestation associated with neonatal outcome. AM 3 OBSTET GYNECOL, 1985 Nov 15;
153(6):651-4.
96. Reece EA, Coustan DR, Hsyslett JP, Holford T, Ct al: Diabetic nephropathy: pregnancy performance and fetomaternal outcome, AM 3 OBSTET GYNECOL, 1988 Jul;
159(l):5~66.
97. Tevaarwerk GJ, Harding PG, Milne RI, Jaco NT, et al: Pregnancy in diabetic women: outcome with a program aimed at normoglycemia before meals, CAN MED ASSOC 3,1981
Sep 1; 125(5):435A0.
98. Dc Muylder X: Perinatal complications of gestational diabetes: the influence of the timing of the diagnosis, EUR 3 OBSTET GYNECOL REPROD BIOL, 1984 Sep; 18(l-2):35-
42.
99. Philipson EH, Kalhan SC, Edelberg SC, Wjllisms TG: Maternal obesity as a risk factor in gestational diabetes, AM 3 PERINATOL, 1985 Oct; 2(4):268-70.
100. Morisa FH Jr: Infants of diabetic mothers. Fetal and neonatal pathophysiology, PERSPECT PEDIATR PATHOL, 1984 Fali; 8(3):223-34.
101. Peevy RI, Landaw SA, Gross SJ: Hyperbilirubinemia in infants of diabetic mothers, PEDIATRICS, 1980 Sep; 66(3):417-19.
102. Fallucca F, Maldonsto A, Iavicoli M, Di Rolin G, et al: Influence of maternal metabolic control and insulin anitbodies on neonatal complications and b-cell function in infants of
diabetic mothers, DIBETES RES CUN PRACT, 1989 Nov 6; 7(4):277-84.
103. Barrett JM, Boebm FH: Comparison of aggressive and conservative management of premature rupture of fetal membranes, AM 3 OBSTET GYNECOL, 1982 Sep 1; 144(l):12-16.
104. Haultkamss M, Nilason CG, Luukkainen T: Screening, management, and outcome of pregnancy in diabetic mothers, OBSTET GYNECOL, 1980 May; 55(5):596-602.
105. Budhrajs M, Danel I: Control of overt maternal diabetes during pregnancy in a county hospital. ARCH INT MED. 1986 Feb; 146(2):31 1-5.
106. Drexel H. Bickler A, Sailer S, Brejer C, Ct ii: Prevention of perinatal morbidity by tight metabolic control in gestational diabetes mellitus, DIABETES CARE, 1988 Nov-Dec; 1
1(l0):761 -8.
107. Miodovulk M, Mimouni F, Tsang RC. Skiliman C, et al: Management of the insulin-dependent diabetic during labor and delivery. Influences on neonatal Outcome, AM J PERINATOL,
1987 Apr; 4(2):106-14.
108. Diamond MP, Shah DM, Hester RA, Vaughn WK, et al: Complications of insulin-dependent diabetic pregnancies by preeclampsia and/or chronic hypertension: analysis of Outcome,
AM J PERINATOL, 1985 Oct; 2(4):263-7.
109. Osbom LM, Reiff MJ, Bolos R: Jaundice in the full-term neonate. PEDIATRICS, 1984 Apr; 73(4):520-5.
110. Kiviahan C, James EJ: The natural history of neonatal jaundice, PEDIATRICS, 1984 Sep; 74(3):364-70.
111. Adams JA, Hey DJ, Hall ItT: Incidence of hyperbilirubineenia in breast- vs. formula-fed infants, CLIN PEDIATR (PHILA), 198S Feb; 24(2):69-73.
112. Saigal S. Lunyk 0, Bennett KJ, Patteeson MC: Serum bilirubin levels in breast- and formula-fed infants in the first five days of life, CAN MIED ASSOC 3. 1982 Nov; 127(l0):985-
9.
113. Hall RT, Braun WJ, Callenhach JC. Metttl K, et al: Hyperbilirubinemia in breast- versus formula-fed infants in the first six weeks of life: relationship to weight gain, AM J PERINATOL,
1983 Oct; l(1):47-51.
114. Maisels Mt, Gifford K: Neonatal jaundice in full-term infants. Role of breast feeding and other causes, AM J DIS CHILD, 1983 Jun; 137(6):561-2.
115. Auerbach KG, Ganner LM: Breast feeding and human milk: their association with jaundice in the neonate, CLIN PERINAT, 1987 Mar; 14(l):89-107.
116. Dahms B, Krauss A, Gartner L, et at: Breast feeding and serum bilirubin values during the first 4 days of life, J PEDIATR, 83(6):1049-54.
117. Mewman 3: Breast feeding problems associated with the early introduction of bottles and pacifiers, 3 HUM LACT, 1990 Jun; 6(2):59-63.
118. Dc Carvalho M, Robertson S, Klaus M: Fecal bilirubin excretion and serum bilirubin concentrations in breast-fed and bottle-fed infants, 3 PEDIATR, 1985 Nov; 107(5):786-90.
119. Gartner LM, Lee KS, Moscioni AD: Effect of milk feeding on intestinal bilirubin absorption in the rat, J PEDIATR, 1983 Sep; 103(3):464-71.
120. Poland RL, Schulte GE, Gaeg 0: Fligh milk lipase activity associated with breast milk jaundice, PEDIATR RES. 1980 Dec; 14(12):1328-31.
121. Chappell JE. Clandinin MT, MeVey MA, Chance GW: Free fatty acid content of human milk: physiologic significance and artifactual determinants, UPIDS, 1985 Apr; 20(4):216-
21.
122. Berde CB, Benitr WE, Rasmussen LF, Kemer JA, Ct al: Bilirubin binding in the plasma of newborns: critical evaluation of a fluorescence quenching method and comparison to the
peroxidase method, PEDIATR RES, 1984 Apr; 18(4):349-54.
123. Fekete M. Kardus M: Jaundice in preterm infants with hypoxia of various severity, ACTA PEDIATR ACAD SCI IIUNG, 1979; 20(4): 321-7.
124. Dunn L, Hulman S, Weiner 3, Kliegman R: Beneficial effects of early hypocaloric enteral feeding on neonatal gastrointestinal function: preliminary report of a randomized trial, J
PEDIATR, 1988 Apr; 112(4):622-9.
125. Jirsova V, Janoveky M: Hyperbilirubinemia connected with parenteral administration of higher amounts of fluids in premature infants, BIOL NEONATH, 1978; 33(3-4):132-4.
126. Beck It: Use of a pediatric parenteral amino acid mixture in a population of extremely low birth weight neonates: frequency and spectrum of direct bilirubinemia, AM J PERINATOL,
1990 Jan; 7(l):84-6.
127. Girm-Pease ME. Pantalos D, King DR: TPN-associated hyperbilirubinemia: a common problem in newborn surgical patients. J PEDIATR SURO, 1985 Aug; 20(4):436-9.
128. Kobota A, Okada A, Neru R, Kamata S, Ct al: Hyperbilirubinemia in neonates associated with total parenteral nutrition, IPAN J PARENTER ENTER NUTR, 1988 Nov-Dec;
12(6):602-6.
VII-2
129. Spear ML, Stahl GE, Paul MH, Egler JM, et al: The effect of 15-hour fat infusions of varying dosage on bilirubin binding to albumin, JPAN 3 PAIENTNR ENTERAL NUTR,
1985 Mar-Apr. 9(2):144-7.
130. Benjamin DR: Hepatobiliary dysfunction in infants and children associated with long-term total parenteral nutrition. A clinico-pathologic study, AM 3 CLINPATHOL, 1981 Sep;
76(3): 276-83.
131. Hughes CA, Talbot IC, Ducker DA. Harran MJ: Total parenteral nutrition in infancy: effect on the liver and suggested pathogenesia, GUT, 1983 Mar; 24(3):241-8.
132. Cooper A, Betts JM, Pereira GR, Ziegler MM: Taurine deficiency in the severe hepatic dysfunction complicating total parenteral nutrition, 3 PEDIATR SURG, 1984 Aug;
19(4):462-6.
133. Cooper A. Ross AJ 3rd, O’Neill JA Jr, Bishop HC, Ct al: Resolution of intractable cholestasis associated with total parenteral nutrition following biliary irrigation, 3 PEDIATR
SLRG, 1985 Dec; 20(6):772-4.
134. Ojo CO, Dawodu AH, Osifo BO: Vitamin E deficiency in the pathogenesis of hemolysis and hyperbilirubinemia of neonatal jaundice, 3 TROP PED, 1986 Oct; 32(5):251-4.
135. Sheriff DS, Ghwansha K, Bax AJ, Gengen KB, et al: Serum vitamin E status in infants with neonatal hyperbilirubinemia, AM 3 OB GYN, 1986 Nov; 155(5):1 142-3.
136. Turmen T, Thom P, Louridas AT, LeMorvan P, Aranda JV: Protein binding and bilirubin displacing properties of bumetanide and furosemide, 3 CLIN PIIARMACOL, 1982 Nov-
Dec; 22(11-12)551-6.
137. Wadsworth SJ, Svh B: In vitro displacement of bilirubin by antibiotics and 2-hydroxybeneoylglycine in newborns, ANTIMECROB AGENT CIIEMOTTIER, 1988 Oct;
32(l0):1571-5.
138. Venkataraman PS, Babcock DS, Tsang RC, Ballard 3L: Hepatic injury: a possible complication of dopamine infusion through an inappropriately placed umbilical vein catheter,
AM J PERINATOL, 1984 Jul, 1(4):351A.
139. Thomton VS, Bowe liT: Neonatal hyperbilirubinemia after therapy of maternal leprosy, SOUTH MED 3, 1989 May; 82(5):668.
140. Ferrante A, Thong YH: Inhibition of serum bactericidal activity of bilirubin, IMMUNOL LETT. 1982 Feb; 4(2):103-5.
141. Raymond GG, DeGennaro MD, Yau M, Buice RG: Effect of hyperbilirubinemia on the pharmacokinetics of diazepam in the rat, RES COMMUN CHEM PATHOL PIIARMACOL,
1980 Apr; 28(l):133-44.
142. Linder N, Yatsiv It, Tsur M, Matoth I, et al: Unexplained neonatal jaundice as an early diagnostic sign of septicemia in the newborn, 3 PERINATOL, 1988 Fall; 8(4):325-7.
143. Moomjian AS, Sokal MM, Vijayan S: Pathogenicity of alpha hemolytic streptococci in the neonate, AM 3 PERINATOL, 1984 Jul; 1(4):319-21.
144. Imura K, Fukui Y. Yagi M, Nakai S: Perioperative change of plasma endotoxin levels in early infants, 3 PED SURG, 1989 Dec; 24(12):1232-5.
145. Goldberg PK. Koziun PJ. Kodsi B, Lewitis It, Ct al: Endotoxemia and hyperbilirubinemia in the neonate, AM 3 DIS CHILD, 1982 Sep; 136(9):845-8.
146. Miler I, Sima P, Vetvicka V, Indrova M, Slavikova M: The potential immunosuppressive effect of bilirubin, ALLERG IMMIINOL (LEIPZ), 1988; 34(3):177-84.
147. Sethi RK, Mishra MK, Sethi A, Saxena KP, Kumar R: Immunologic profile in neonatal hyperbilirubinemia, INDIAN PEDIATR, 1989 Aug; 26(8):787-92.
148. Mebta P, Vasa It, Neumann L, Karpatirin M: Thrombocytopenia in the high-risk infant, 3 PEDIATR, 1980 Nov; 97(5):791-4.
149. Dikshit SK, Gupta PK: Exchange transfusion in neonatal hyperbilirubinemia. INDIAN PEDIATR, 1989 Nov; 26(l1):1139-45.
150. Cashore WJ, Oh W: Unbound bilirubin and kernicterus in low-birth-weight infants, PEDIATRICS, 1982 Apr; 69(4):481-5.
151. Harper PG, Kahn El, Sia CG. Horn D. Ct al: Patterns of bilirubin staining in nonhemolytic kernicterus, ARCH PATH LAB MED, 1986 Jul; 110(7):614-7.
152. Lucey JE: Neonatal Jaundice and Phototherapy. PED CUN N AM, 1972 Nov; 19(4):827-38.
153. van de Bor M, van Zeben-van der Aa TM, Verloove-Vanhorick SP, Brand It, Roys JH: Hyperbilirubinemia in preterm infants and neurodevelopmental outcome at 2 years of age:
results of a national collaborative survey, PEDIATRICS, 1989 Jun; 83(6): 915-20.
154. Ellis MI: Follow-up study of survivors after intra-uterine transfusion, DEV MED CHILD NEUROL, 1980 Feb; 22(l):48-54.
155. Boggs T, Hardy J, Frazier T: Correlation of neonatal serum total bilirubin concentrations and developmental status at age eight months, 3 PEDIATR, 1967 Oct; 71(4):553-60.
156. Rubin R. Balow B. Fiach R: Neonatal serum bilirubin levels related to cognitive development at ages 4 through 7 years, J PEDIATR, 1979 Apr; 94(4):601-4.
157. Lenhardt ML: Effects of neonatal hyperbilirubinemia on Token Teat performance of ah-year-old children. J AUD RES. 1983 Jul; 23(3):195-204.
158. Shucard DW, Shucaed JL, Thornaa DG: Neurophysiological studies of human cognitive development in premature infants: an approach to the study of maturational brain processes,
NEUROTOXICOL, 1988 Fall; 9(3):299-316.
159. Nilsen ST, Finne PH, Bergej P, Stamnea 0: Males with neonatal hyperbilirubinemia examined at 18 years of age, ACTA PEDIATR SCAND, 1984 Mar; 73(2):176-80.
160. Karplus M, Lce C, Cashore WJ, Oh W: The effects of brain bilirubin deposition on auditory brain stem evoked responses in rats, EARLY IIUMAN DEVEL, 1988 Mar;
16(2.3):185-94.
161. Nakamura H, Takada S, Shimabuku R, Matsuo M, et al: Auditory nerve and brain stem responses in newborn infants with hyperbilirubinemia, PEDIATRICS, 1985 Apr; 75(4):703-
8.
162. Swigonski N, Shallop 3, Bull Ml, Lemons JA: Hearing screening of high risk newborns, EAR HEAR, 1987 Feb; g(l):26-30.
163. Simmons FB: Patterns of deafness in newborns, LARYNGOSCOPE, 1980 Mar; 90(3):448-53.
164. de Vries LS, Lary S. Dubowitz LM: Relationship of serum bilirubin levels to ototoxicity and deafness in high-risk low-birth-weight infants. PEDIATRICS, 1985 Sep; 76(3):351A.
165. Anagnostakis D, Petmazakis 3, Papazissis 0, Ct al: Hearing loss in low-birth-weight infants, AM 3 DIS CHILD, 1982 Jul; 136(7):602-4.
166. Paneth N: Etiologic factors in cerebral palsy, PED ANN, 1986 Mar; 15(3):191,4-5,7-201.
167. Veelken N, Hagberg B, Hagberg 0, Glow I: Diplegic cerebral palsy in Swedish term and preterm children. Differences in reduced optimality, relations to neurology and pathogenic
factors, NEUROPEDIATR, 1983 Feb; 14(l):20-8.
168. Kyilennan M: Dyakinetic cerebral palsy. 11. Pathogenetic risk factors and intrauterine growth, ACTA PEDIATR SCAND, 1982 Jul; 71(4):551-8.
169. Kyliennan M: Reduced optimality in pre- and perinatal conditions in dyskinetic cerebral palsy distribution and comparison to controls, NEUROPEDIATR, 1983 Feb; 14(l):29-36.
170. Koo H, Roessrnann U: Astrocyte response to perinatal liver disease, hyperammonemia and hyperbilirubinemia: an immunohistochemical study, PED PATHOL, 1988; 8(3):301-ll.
171. Rosenthal P, Blanckaert N, Kabra PM, Thaler MM: Formation of bilirubin conjugates in human newborns, PED RES, 1986 Oct; 20(l0):947-50.
172. Streletr U, Grariani U, Brance PA, Desa HI. Ct al: Brainstem auditory evoked potentials in full term and preterm newborns with hyperbilirubinemia and hypoxemia. NEUROPEDS,
1986 May; l7(2):~7l.
173. Pearlman MA, Gartner LM, Lee K, Eidclman Al, Ct all The association of kernicterus with bacterial infection in the newborn, PEDIATRICS, 1980 Jan; 65(l):26-9.
174. Lucey 1: Bilirubin and brain damage – a real mess, PEDIATRICS, 1982 Mar; 69(3):381.2.
175. Turkel S, Mitler C, Guttenbcrg M, et al: A clinical pathological reappraisal of kernicterus, PEDIATRICS, 1982 Mar; 69(3):267-72.
176. Turtel SB, Guttenberg ME, Moynes DR, Hedgrnan JE: Lack of identifiable risk factors for kernicterus, PEDIATRICS, 1980 Oct; 66(4):502-6.
177. Arnato M, Fauchere JC, von Muralt 0: Relationship between peri-intraventricular hemorrhage and neonatal hyperbilirubinemia in very low birth weight infants, AM I PERINATOL.
1987 Oct; 4(4):275-8.
178. Payne NR, Hasegaws DK: Vitamin K deficiency in newborns: a case report in alpha-1-antitrypsin deficiency and a review of factors predisposing to hemorrhage, PEDIATRICS,
1984 May; 73(5):712-6.
179. Ives NK, Bolas NM, Gardiner RM: The effects of bilirubin on brain energy metabolism during hyperosmolar opening of the blood-brain barrier, PED RES. 1989 Oct; 26(4):35661.
180. Levine R, Fredericks W, Rapoport S: Entry of bilirubin into the brain due to opening of the blood-brain barrier, PEDIATRICS. 1982 Mar; 69(3):255-9.
181. Lee C, Oh W, Stoneatreet BS, Cashure WI: Permeability of the blood-brain barrier for 125 I-albumin-bound bilirubin in newborn piglets, PED RES, 1989 May; 25(5):452-6.
182. Jirka JH, Duckrow RB, Kendig 1W, Maiscis Ml: Effect of bilirubin on brainstem evoked potentials in the asphyxiated rat, PED RES, 1985 Jun; 19(6):556-60.
183. Turkel SB, Miller CA. Guttenberg ME, Moynes DR, Godgman JE: A clinical pathologic reappraisal of kernicterus, PEDIATRICS, 1982 Mar; 69(3):267-72.
184. Roth P. Polin RA: Controversial topics in kernicterus, CUN PERIJNATOL. 1988 Dec; 15(4):965-90.
185. Sisson TR: Molecular basis of hyperbilirubinemia and phototherapy, J INVEST DERMATOL. 1981 Jul; 99(l):86-8.
186. Ou CN, Buffone 10, Herr-Calomeni P1, et al: Unconjugated hyperbilirubinemia is overestimated in neonates with chlestasis. A more reliable method is proposed, AM I CLIN
PATHOL. 1985 Dec; 84(6):752-6.
187. Bonds DR, Gabbo 50, Kumar S, Taylor T: Fetal weight I placental weight ratio and perinatal outcome, AM I OBSTET GYNECOL. 1984 May 15; 149(2):195-200.
188. Rosenfeld J: Umbilical cord bilirubin levels as a predictor of subsequent hyperbilirubinemia. 3 FAM PRACT, 1986 Dcc; 23(6):556-8.
189. Jacobson MP. Bernstein HH: Limited diagnostic value of routine cord blood bilirubin determinations, CLIN PEDIATR (PHILA), 1982 Oct; 21(l0):610-2.
190. Wennberg RP, Depp K, Heirricha WL: Indications for early exchange transfusion in patients with erythroblastosis fetalis, I PEDIATR, 1978 May; 92(5):789-92.
191. Vreman HI, Redgera PA. Gale R, Stevenson DK: CO excretion as an index of bilirubin production in Rhesus monkeys, 3 MED PERINATOL, 1989; 18(6):449-60.
192. Uctani Y, Nakamura H, Okarnoto 0, Yamazaki T, et al: Carboxyhemoglobin measurements in the diagnosis of ABO hemolytic disease. ACTA PEDIATR IPAN OVERSEAS ED,
1989 Apr; 31(2):171-6.
193. Chen SH: Endogenous formation of carbon monoxide in Chinese newborn with hyperbilirubinemia. TAIWAN I HSUEH HUI TSA CHIH. 1981 Jan; 80(l):68-77.
194. Chen SH, Chen LY. Chen IS: Carboxyhemoglobin and serum hepatic enzymes in newborns with hyperbilirubinemia. TAIWAN I HSUEH HUI TSA CHIH,1986 Feb; 85(2):l0l-8.
195. Cohen KS, Ostrander CR. Cohen BE, Stevens GB. Ct al: Pulmonary excretion rates of carbon monoxide using a modified technique: differences between premature and full-term
infants. BIOL NEONATH. 1982; 41(5-6):289-93.
VII-3
196. Yamauchi Y. Yarnanpuchi I: Clinical application of transcutaneous bilirubin measurement, ACTA PEDIATR SCAND, 1990 Apr; 79(4):385-90.
197. Bhardwsj HP. Narang A. Bhakoo ON: Evaluation of Minolta jaundicemeter and icterometer for assessment of neonatal jaundice, INDIAN PED, 1989 Feb; 26(2):161-5.
198. Schumacher RE, Thomberry JM, Guteher OR: Transcutaneous bilirubinometry: a comparison of old and new methods, PEDIATRICS, 1985 Jul; 76(l):l0-4.
199. Hegg T: Transcutaneous bilirubinometry in the newborn infant: state of the art, 3 CLIN MONIT. 1986 Jan; 2(l):53-9.
200. Maisels Ml, Conrad S: Transcutaneous bilirubin measurements in full-term infants, PEDIATRICS, 1982 Sep; 70(3):464-7.
201. Hegyi T, Hiatt IM. Indyk L: Transcutaneous bilirubinometry. I. Correlations in term infants, J PEDIATR, 1981 Mar; 98(3):454-7.
202. Maisels Ml. Gifford K: Normal serum bilirubin levels in the newborn and the effect of breast feeding. PEDIATRICS. 1986 Nov; 78(5):837-43.
203. Newman Th. Easterling MI, Goldman ES, Stevcnaon DK: Laboratory evaluation of jaundice in newborns. Frequency, cost, and yield, AM I DIS CHILD, 1990 Mar; 144(3):364-8.
204. Rosenthal P, Sinatra F: Jaundice in infancy, PED REV, 1989 Sep; 11(3):79-86.
205. Cashore WJ. Oh W, Brodersen R: Reserve albumin and bilirubin toxicity index in infant serum, ACTA PEDIATR SCAND, 1983 May; 72(3):415-9.
206. Hwang KC, Hsieh KH, Chen Ill: Immunological studies of newborn infants with hyperbilirubinemia, CHUNG HUA MIN KUG WEI SHENG WU CIII MIEN I HSUEII TSA
CHIH, 1981 Jun; 14(2):65-72.
207. Tolaymat N, Figueros-Colon R, Mitros PA: Alpha-l-antirypsin deficiency and biliary atresis, J PED GASTHOE~~ NUTR, 1989 Au8; 9(2):256-60.
208. Sanna 0, Frau F, DC Virgilus S, Piu P, ct al: Glucose-6-phosphate dehydrogenase red blood cell phenotype in GdMediterranean heterozygous females and hemizygous males at
birth, PEDIATR RES, 1981 Nov; 15(11):1443-6.
209. Yachha 5K, Marwaha RK, Narang A, Mohanty D: G6PD isoenzyme pattern and evaluation of screening methods for G6PD deficiency in neonatal hyperbilirubinemia, INDIAN
PED, 1987 Dec; 24(12):1099-104.
210. Bunton EM, Babcock DS, Heubi JE, Gelfand Ml: Neonatal jaundice: clinical and ultrasonographic findings, SOUTH MED 3, 1990 Mar; 83(3):29~302.
211. Cox KL, Stadalnik RC, KcGahan 3P, Sanders K, et al: Hepatobiliary scintography with technetium 99m disofenin in the evaluation of neonatal choleatasia, 3 PED GASTROENT
NUTH, 1987 Nov-Dec; 6(6):885-91.
212. Tolia V, Kuins L, Dubois RS: Role of 99m Tc-diaofenin in duodenal and gastric aspirates in the evaluation of persistent neonatal cholestasia, 3 PEDIATR GASTROENT NUTR,
1989 Nov; 9(4):426-30.
213. Kurnura D, MIller JH, Sinatra FR: Septo-optic dysplasia: recognition of causes of false-positive hepatobiliary scintography in neonatal jaundice, 3 NUCL MED, 1987 Jun;
28(6);96072.
214. Banagale RC: Rapid fluorometric assay of bilirubin binding parameters in newborn infants, RES COMMUN CISEM PATHOL PHARMACOL, 1985 Apr; 48(l):99-120.
215. Auditory brainstem responses in patients with neonatal hyperbilirubinemia and bilirubin encephalopathy, BRAIN DEV, 1989; 1 l(5):297-301.
216. Ouvrier RA: Advances in neonatal neurology, BRAIN DEV, 1984; 6(6):52O~7.
217. Hall JW 3rd, Brown DP, Mackey-Hargadine JR: Pediatric applications of aerial auditory brainstem and middie4atency evoked response recordings, INT 3 PEDIATR
OT0RI~OLARYNGOL, 1985 Aug; 9(3):201-18.
218. Soarea I, Collet L, Delorme C, Salle B, Morgan A: Are click-evoked BAEPs useful in case of neonate hyperbilirubinemia?, INT 3 PED OTORHINOLARYNGOL, 1989 Jul;
17(3):231-7.
219. Mjen S, Langalet A, Tangarud SE, Sundby A: Auditory brainstem responses (ABR) in high-risk neonates, ACTA PEDIATR SCAND, 1982 Sep; 71(5):711-5.
220. Vohi BR, Lester B, Rapisardi G, Odes C, Ct al: Abnormal brainstem function (brainstem auditory evoked responses) correlates with acoustic cry features in term infants with
hyperbilirubinemia, 3 PEDIATR, 1989 Aug; 1 15(2):303-8.
221. Rapisardi 0, Vohr B, Cashore W, Peuker M, Lester B: Assessment of infant cry variability in high-risk infants, ‘NT J PED OTORHINOLARYNGOL, 1989 Feb; 17(l):19-29.
222. Roberts JL, Davis H. Phon GL, Reichert T3, et al: Auditory brainstem responses in preterm neonates: maturation and follow-up, J PEDIATR, 1982 Aug; 101 (2):257-63.
223. Nwaesei CO, Van Aerde J. Boyden M, PerIman M: Changes in auditory brainstem responses in hyperbilirubinemic infants before and after exchange transfusion, PEDIATRICS,
1984 Nov; 74(5):800-3.
224. DeVries LS, Lary S. Whitelsw AG, Dubowitx LM: Relationship of serum bilirubin levels and hearing impairment in newborn infants, EARLY HUM DEV, 1987 Sep; 15(5):269.77.
225. Kuriyama M, Tomiwa K, Konishi Y, Mikawa H: Improvement in auditory brainstem response of hyperbilirubinernic infants after exchange transfusion, PED NEUR, 1986 May-
Jun; 2(3):127-32.
226. Wennberg ItP, Ahifors CE, Bickers R, McMurtry CA, Shetter JL: Abnormal auditory brainstem response in a newborn infant with hyperbilirubinemia: improved with exchange
transfusion, 3 PEDIATR, 1982 Apr; l00(4):624-6.
227. Kurlysma M, Konishi Y, Mikawa H: The effect of neonatal hyperbilirubinemia on the auditory brainstem response, BRAIN DEV, 1986; 8(3):240-5.
228. Thoma 3, Gerull G, Mrowinslti D: A long term study of hearing in children following neonatal hyperbilirubinemia, ARCH OTORHINOLARYNGOL, 1986; 243(2): 133.7.
229. Paludetxo R, Mansi G, Rinaldi P, Ariola P, Cascioli CF: Moderate hyperbilirubinemia does not influence the behavior of jaundiced infants, BIOL NEONATE, 1986; 50(l):43.7.
230. Eacher-Graub DC, Fricker HS: Jaundice and behavioral organization in the full-term neonate, HELV PEDIATR ACTA, 1986 Dec; 41(5):425-35.
231. Chen HY: Artemisia composite for the prevention and treatment of neonatal hemolysia and hyperbilirubinemia, J TRADIT CHIN MED, 1987 Jun; 7(2):105-8.
232. Fischer AF, Inguillo D, Martin DM, Ochtkubo CG, Ct al: Carhoxyhemoglobin concentration as an index of bilirubin production in neonates with birth weight under 1500 grams: a
randomized double-blind comparison of supplemental oral vitamin E and placebo, 3 PED GASTROENTEROL NUTR. 1987 Sep-Oct; 6(5):748-51.
233. Knoblork E, Hodr R, Herxrnann 3, Prorhszokva E, Houskova V: Reversible photoreduction of flavin with bilirubin II, ACTA VITAMINOL ENZYMOL, 1984; 6(4):313-24.
234. Yurdakok M, Erdern G, Tekinalp G: Riboflavin in the treatment of neonatal hyperbilirubinemia, TURK 3 MED, 1988 Jul-Sep; 30(3):159-60.
235. Weisman IE, Merenstein GB, Digirol M, Collins 3, Ct al: The effect of early meconium evacuation on early Onset hyperbilirubinemia, AM 3 DIS CHIU), 1983 Jul; 137(7):666-8.
236. Epstein ME, Leviton A, Kuban KC, Pagano M. Ct al: Bilirubin, intraventricular hemorrhage, and phenobarbital in very low birth weight babies, PEDIATRICS, 1988 Sep;
82(3):350-4.
237. Valaes T, Kipouros K, Petmaraki S. Solman M, Doxiadis SA: Effectiveness and safety of prenatal phenobarbital for the prevention of neonatal jaundice, PEDIATR RES, 1980 Aug;
14(8): 947-52.
238. Rayburn W, Dunn S. Pichie E, Compton A: Antenatal phenobarbital and bilirubin metabolism in the very low birth weight infant, AM 3 GB GYN, 1988 Dec; 159(6):1491-3.
239. Wallin A, Boreus LO: Phenobarbital prophylaxis for hyperbilirubinemia in preterm infants. A controlled study of bilirubin disappearance and infant behavior, ACTA PEDIATR
SCAND, 1984 Jul; 73(4):488-97.
240. Gravel L. Aimanza M, Alvarer R, Garria D, et al: Induction of bilirubin-eliminating processes by methyl phenobarbital in mature newborn babies, J PERINAT MED, 1988; 16(5-
6):431-5.
241. Anwar M, Valdivieso 3, IIi5tt IM, Hegyt T: The course of hyperbilirubinemia in the very low birth weight infant treated with phenobarbital, 3 PERINATOL, 1987 Spring;
7(2):145-8.
242. Drummond OS, Kappas A: Sn-protoporphyrin inhibition of fetal and neonatal brain hemeoxygenase. Transplacental passage of the metallo-porphyrin and prenatal suppression of
hyperbilirubinemia in the newborn animal, J CUN INVEST, 1986 Mar; 77(3):971-6.
243. Kappas A, Drummond OS, Manola T, Petmezski S, Valaes T: Sn-protoporphyrin use in the management of hyperbilirubinemia in term newborns with direct Coomba-positive ABO
incompatibility, PEDIATRICS, 1988 Apr; 81(4):485-97.
244. Ferber S, Rosenthal P, Henton D: The effect of tin-protoporphyrin in bilirubin conjugation and production of cholestasis in r5ts. PED RES, 1988 Feb; 23(2):163-6.
245. Drummond OS, Kappas A: An experimental model of postnatal jaundice in the suckling rat. Suppression of induced hyperbilirubinemia by Sn-protoporphyrin, J CLIN INVEST,
1984 Jul; 74(l):142-9.
246. Cornelius CE, Redgers PA: Prevention of neonatal hyperbilirubinemia in Rhesus monkeys by tin-protoporphyrin. PED RES, 1984 Aug; 18(8):728-30.
247. Drummond OS, Kappas A: Prevention of neonatal hyperbilirubinemia by tin-protoporphyrin IX, a potent competitive inhibitor of heme oxidation, PROC NATL ACAD SCI USA,
1981 Oct; 78(l0):6466-70.
248. Land El, McDonagh AF, Mcoarvey D3, Truscott TO: Photophysical studies of tin(IV)-protopornhyrin: potential phototosicity of a chemotherapeutic agent proposed for the prevention
of neonatal jaundice, PROC NATL ACAD SCI USA. 1988 Jul; 85(14):5249-53.
249. Hovi L, Sitmes MA: Exchange transfusion with fresh heparinized blood is a safe procedure. Experiences from 1069 newborns. ACTA PEDIATR SCAND, 1985 May; 74(3):360-5.
250. Haysahi K, Kondo T, Nosaka K. Yarnanaka S, Ct al: A successful delivery of an externally immature infant in Rh incompatibility after exchange transfusion, KEIG J MED, 1989
Jun; 38(2):184-91.
251. Amato M, Blumbeeg A, Hermann V Jr, Zurbrugg R: Effectiveness of single and double exchange transfusions in newborn infants with ABO hernolytic diarase, HELV PEDIATR
ACTA, 1955 Nov; 43(3):177-86.
252. Carapella Dc Luca E, Stegagno M: Blood transfusion therapy in the newborn, HEMATOLOGIA ~UDP), 1951; 14(2):173-90.
253. Kojima T. Hirata Y, Urneda Y, Sato Y, et al: Role of atrial natiuretic peptide in the diuresis of a newborn infant with the syndrome of inappropriate antidiuretic hormone secretion,
ACTA PEDIATR SCAND. 1959 Sep; 78(5):793-6.
254. Jasso-Gutierrez L, Riro-Hemandri A, de la Rosa L: Effects of exchange transfusion on platelet counts. ARCH INVEST MED (MEX), 1981; 12(3):297-306.
VII-4
255. Francois J: Risk factors for retrolental fibroplasia, OPHTHALMOLOGICA, 1983; 186(4):189-96.
256. Adsmkin DH, Shott U, Cook LN, Andrews BF: Nonhyperoxic retrolental fibroplasia, PEDIATRICS, 1977 Dec; 60(6):828-30.
257. Seemayer TA, Bolande RP: Thymic involution mimicking thymic dysplasia: a consequence of transfusion-induced graft vs. host disease in a premature infant, ARCH PATHOL
LAB MED, 1980 Mar; 104(3):141-4.
258. Lauer BA, Githens JH, Hayward AR. Conrad PD. Ct al: Probable graft vs. graft reaction in an infant after exchange transfusion and marrow transplantation, PEDIATRICS, 1982
Jul; 70(l):43-7.
259. Wright K, Tare P1. Hickman RO, Guthrie RD: Hyperbilirubinemia secondary to delayed absorption of intraperitoneal blood following intrauterine transfusion, J PEDIATR, 1982
Feb; l00(2):302-4.
260. Bowman JM: Hyperbilirubinemia secondary to delayed absorption of intraperitoneal blood following intrauterine transfusion (1ettsr), J PEDIATIt, 1982 Sep; l0l(3):482-3.
261. Vaughan RL: Morbidity due to exchange transfusion with heat hemolyzed blood, AM J DIS CmLD, 1982 Jul; 136(7):646-8.
262. Rovarno L, NikItils EA, Taskinen MR. Raivio KO: Post heparin plasma lipoprotein and hepatic lipases in preterm neonates, PEDIATR RES. 1984 Nov; 18(1 l):1 104-7.
263. Sjoberg P0, Bondesson UG. Sedin EG, Gustafsson JP: Exposure of newborn infants to plasticizers. Plasma levels di-(2-ethylhexyl) phthalate and mono-(2-ethylbexyl) phthalate
during exchange transfusion, TRANSFUSION. 1985 Sep-Oct; 25(5):424-8.
264. Gulati S, Singh S, Narang A, Bhakoo ON: Exchange transfusion with G-6-PD deficiency donor blood causes exaggeration of neonatal hyperbilirubinemia, INDIAN PEDIATR.
1989 May; 26(5):499-501.
265. Sideman S, Mor L, Brandes JM, Lupovitch S: Preparation of a biocompatible albumin-coated ion exchange resin for bilirubin removal from the blood of jaundiced newborns, J
BIOMIED MATER RES, 1983 Jan; 17(1):91-107.
266. Sideman S, Mor L, Mihich M. Mordohovich D, et al: Resin hemoperfusion for unconjugated bilirubin removal, CONTRIB NEPHROL, 1982; 29:90-100.
267. Rycainan FC, Noseworthy J: Neonatal cholestatic conditions requiring surgical reconstruction, SEMIIN LIV DIS, 1987 May; 7(2):134-54.
268. Houwen RH. Zwierstra RP, Severejnen RS, Bouquet J, Ct al: Prognosis of extrahepatic biliary atresia, ARCH DIS CHILD, 1989 Feb; 64(2):214-8.
269. Altman RP: The portoenterostomy procedure for biliary atresia: a five year experience, ANN SURO, 1978 Sep; 188(3):351-62.
270. Osbom LM, Bolus R: Breast feeding and jaundice in the first week of life, 3 FAM PRAC, 1985 May; 20(5):475-80.
271. Amato M, Howald H, von Muralt G: Interruption of breast feeding vs. phototherapy as treatment of hyperbilirubinemia in full-term infants, HELV PEDIATR ACTA, 1985 Jul;
40(2-3):127-31.
272. Lall JC, Khosla D, Sood SC, Singhal SC: Phototherapy vs. photobarb in the management of neonatal hyperbilirubinemia, INDIAN J PEDIATR, 1982 Jul-Aug; 49(399):525-8.
273. Seheidt PC. Bryla DA, Nelson KB, Hirtz DG. Hoffman Hi: Phototherapy for neonatal hyperbilirubinemia: 6 year follow-up of the National Institute of Child Health and Human
Development clinical trial, PEDIATRICS, 1990 Apr; 85(4):455-63.
274. Cremer RJ, Perryman PW, Richards DII: Influence of light on the hyperbilirubinemia of infants, LANCET, 1958; 1:1094.
275. Brown A, McDonagh A: Phototherapy for neonatal hyperbilirubinemia: efficacy, mechanism and toxicity, ADV PEDIATR, 1980; 27:341-89.
276. Clinical trial of the National Institute of Child Health and Human Development and the National Institute of Neurologic Disorders & Stroke, 1991.
277. McDonagh AF: Light effects on transport and excretion of bilirubin in newborns, ANN NY ACAD SCI, 1985; 453:65-72.
278. Patres R. Agati G, Fusi F: Phototherapy for neonatal hyperbilrubinemia. PHOTODERMATOL, 1989 Dec; 6(6):244-57.
279. Lamola AA, Blumbeeg WE, MeClead R, Fanaroff A: Photoisomerized bilirubin in blood from infants receiving phototherapy, PROC NATL ACAD SCI USA, 1981 Mar;
78(3):1882-6.
280. Weise G. Ballowite L: Mathematical description of the temporal changes in serum bilirubin concentration during phototherapy in newborn infants, BIOL NEONATE, 1982; 42(5-
6):222-7.
281. Nakamura H, Lee Y, Uctani Y, Kitaunezuka Y, Ct al: Effects of phototherapy on serum unbound bilizubin in Icteric newborn infants, BIOL NEONATE, 1981; 39(5-6):295-9.
282. MeDonagh A. Lightaser D: like a shriveled blood orange – bilirubin, jaundice, and phototherapy, PEDIATRICS, 1985 Mar; 75(3):443-55.
283. Lightner DA, Lirmane WP 3rd. Ahlfors CE: Bilirubin photooxidation products in the urine of jaundiced neonates receiving phototherapy, PEDIATR RES, 1984 Aug; 18(8):696-
700.
284. Levi N, Trevisan M, Perini R, Tamaro G, et al: Effect of phototherapy on the physiologic cholestasis of the neonate, J PEDIATR GASTROENTEROL NUTR, 1984 Mar; 3(2):230-
3.
285. Odell GB. Guthcer OR, Whitington PF, Yang G: Enteral administration of agar as an effective adjunct to phototherapy of neonatal hyperbilirubinemia, PEDIATR RES, 1983 Oct;
17(10):810-4.
286. Knoblock E, Hodr R, Herzmann 3, Houskova I: ACTA VITAMINOL ENZYMOL, 1981; 3(3):182-7.
287. Hegyi T, Brantley V, Hiatt IM: The effects of shielding the hepatic area on the clinical response to phototherapy, EUR 3 PEDIATR, 1981 Nov; 137(3):303-5.
288. Sisson T, Kendall N, Shaw E, Kechavarz-Olisi L: Phototherapy of jaundice in the newborn infant. II. Effect of various light intensities, J PEDIATR, 1972 Jul; 81(l):35-8.
289. Vecchi C. Donzelli G, Sbrana G, Pratesi R: Phototherapy for neonatal jaundice: clinical equivalence of fluorescent green and “special” blue lamps, J PEDIATR, 1986 Mar;
108(3):452-6.
290. Tan K: Efficacy of fluorescent daylight, blue, and green lamps in the management of nonhemolytic hyperbilirubinemia, 3 PEDIATR. 1989 Jan; 1 14(1):132-6.
291. Romagnoli C, Marrocco G, de Carolis M, Ct al: Phototherapy for hyperbilirubinemia in preterm infants: green versus blue white light, 3 PEDIATR, 1988 Mar; 1 12(3):476-8.
292. Ennever J: Phototherapy in a new light, PED CUN N AM, 1986 Jun; 33(3):603-20.
293. Oski F: Too long for too little, PEDIATRICS, 1985 Jun; 75(6):1151-2.
294. Tan KL, Boey KW: Clinical experience with phototherapy, ANN ACAD MED SINGAPORE, 1989 Jan; 18(l):43-8.
295. Shennan A: The effect of phototherapy on the hyperbilirubinemia of Rhesus incompatibility, PEDIATRICS, 1974 Oct; 54(4):417-21.
296. Ilirsig 3, Rickham PP: Early differential diagnosis between neonatal hepatitis and biliary atresia, J PEDIATR SURG, 1980 Feb; 15(l):13-15.
297. Lipsitr P, Gartoer L, Bryla D: Neonatal and infant mortality in relation to phototherapy, PEDIATRICS, 1985; auppl:422-6.
298. Greenwald SL: Hyperbilirubinemia in otherwise healthy infants, AFP, 1988 Dec; 38(6):151-8.
299. Cockington R: A guide to the use of phototherapy in the management of neonatal hyperbilirubinemia, J PEDIATR, 1979 Aug; 95(2):281-5.
300. Canadian Pediatric Society: Use of phototherapy for neonatal hyperbilirubinemia, CAN MED ASSOC 3,1986 Jun 1; 134:1237-43.
301. Tan KL: Phototherapy for neonatal jaundice in erythrocyte G-6-PD deficient infants, PEDIATRICS, 1977 Jun; 59 Suppl(6 ISt 2): 1023-6.
302. Curtis-Cohen M, Stahi GE, Costarino AT, Polin RA: Randomized trial of prophylactic phototherapy in the infant with very low birth weight, 3 PEDIATR, 1985 Jul; 107(1):1214.
303. National Institute of Child Health and Human Development: Randomized, controlled trials of phototherapy for neonatal hyperbilirubinemia, PEDIATRICS, 1985 Feb; 75(2 Ist
2):385-441.
304. Vaikeakin T, Anttolainen I. Aureskosts H Bjorkqvist S Follow up study of phototreated fullterm newborns, ACTA PEDIATR SCAND, 1981; 70:21-5.
305. Khanna YK, Mebta DK, Matthews M, Naraysnan I: Neonatal hyperbilirubinemia. Ophthalmological evaluation of term infants treated with phototherapy, INDIAN PEDIATR,
1984 Sep; 21(9):713-7.
306. Ashley JR, Littler CM, Burgdorf WH, Brano BS 4th: Bronze baby syndrome. Report of a case, 3 AM ACAD DERMATOL, 1985 Feb; 12(2 Pt l):325-8.
307. Purcell SM, Wians FH Jr, Ackerman NB Jr, Davis BM: Hyperbilirubinemia in the bronze baby syndrome, J AM ACAD DERMATOL, 1987 Jan; 16(1 Pt2):172-7.
308. Luo SF, Huang CC, Wang 3W: Neonatal lupus erythematosis: report of a case, TAIWAN I HSUEH IIUI TSA CHIH, 1989 Aug; 88(8):832-5.
309. Jaehrig K, Balike H. Koenig A, Meisel P: Transepithelial electric potential difference in newborns undergoing phototherapy, PED RES, 1987 Mar, 21(3):283-4.
310. Sivan Y, Dinari G, Goodman C, Merlob P, Nitran M: Small intestine transit time and lactose absorption during phototherapy. BIOL NEONATE, 1985; 48(l):lO-4.
313. Ebbesen F, Edeisten D, Hertel 3: Gut transit time and lactose malabsorption during phototherapy. I. A study using lactose-frec human mature milk, ACTA PEDIATR SCAND, 1980
Jan; 69(l):65-8.
314. Ebbesen F, Edeistein D. Hertal 3: Gut transit time and lactose malabsorption during phototherapy. H. A study using raw milk from the mothers of the infants, ACTA PEDIATR
SCANO, 1980 Jan; 69(l):69-71.
315. Speck WT, Rosenkranz Hs: Phototherapy for neonatal hyperbilirubinemia – a potential environmental health hazard to newborn infants: a review, ENVIRON MUTAGEN, 1979;
l(4):321-36.
316. Parida S, Nanda A: Phototherapy for neonatal hyperbilirubinemia (letter), ARCH DIS CHJLD, 1984; 59:902.
317. Arnato M, von Muralt G, Auf der Maur P: Double direction phototherapy and light-induced genetic abnormalities in human lymphocytes, HELV PEDIATR ACTA, 1985 Sep;
40(4): 285-91.
318. Kenyayan E, Galdi I, Pellicciotta G, Ct al: Effect of phototherapy on plasma levels of GH, LH, and FSH in the newborn, J ENOOCRIINOL INVEST, 1985 Dec; 8(6):561-5.
319. Johnson DO, Bergstrom WIl: Pineal and adrenal effects on calcium homeostasis in the rat, PED RES, 1990 3un; 27(6):571-3.
320. Chandler B, Cashore W, Monin P, Oh W: The lack of effects of phototherapy on neonatal oxygen dissociation curves and hemoglobin concentration in vivo, PEDIATRICS, 1977;
59(Suppl):1027-31.
VII-5
321. Moseley M, Fielder A: Phototherapy: an ocular hazard revisited, ARCH DIS CHILD, 1988; 63:88~7.
322. Paludetto R, Mansi G. Rinaldi P, Dc Curtis M, Ciccimarra F: The behavior of jaundiced infants treated with phototherapy, EARLY HUMAN DEY, 1983 Oct; 8(3-4):259-67.
323. Telitrow R, Snyder D. Tronick E, et al: The behavior of jaundiced infants undergoing phototherapy, DEY MED CHILD NEUROL, 1980 Jun; 22(3):3 17-26.
324. Walther F, Wu P, Siassi B: Cardiac output changes in newborns with hyperbilirubinemia treated with phototherapy. PEDIATRICS, 1985 Dec; 76(6):918-21.
325. Curtis.Cohen M, Stahl G. Costarino A, Ct al: Randomized trial of prophylactic phototherapy in the infant with very low birth weight, J PEDIATR, 1985 Jul; 107(1):121-4.
326. Rubaltolli EF, Piovesan AL. Semenzato 0, Ct al: Immune competence assessment in hyperbilirubinemic newborns before and after phototherapy, HELV PEDIATR ACTA. 1977
Jul; 32(2):129-33.
327. Warshaw JB, Gagliardi 3, Patel A: A comparison of fluorescent and non-fluorescent light sources for phototherapy, PEDIATRICS, 1980 Apr; 65(4):795-8.
328. Sisson T, Kendall N, Shaw E, Kechavarz-Oliai L: Phototherapy of jaundice in the newborn infant. II. Effect of various light intensities, 3 PEDIATR, 1972 Jul; 81(l):35-8.
329. Ayyash H, Hadjiggeorgou E, Sofatris 3, Ct al: Green light phototherapy in newborn infants with ABO hemolytic disease, 3 PEDIATR, 1987 Dec; 111(6 Pt l):882-7.
330. Shrana G, Donzelli GP, Verchi C: Phototherapy in the management of neonatal hyperbilirubinemia: efficacy with light sources emitting more than 500 nm., PEDIATRICS. 1987
Sep; 80(3):395-8.
331. Modi N: Green light phototherapy (letter), 3 PEDIATR, 1986 Nov; 109(5):909.
332. Hegyi T. Graff M. Zapanta V, et al: Transcutaneous bilirubinometry. III. Dermal bilirubin kinetics under green and blue light phototherapy, AM 3 DIS CHILD, 1986 Oct; 140:994-
7.
333. Hammerman C, Eidelman Al, Lee KS, Gartner LM: Comparative measurements of phototherapy: a practical guide, PEDIATRICS, 1981 Mar; 67(3):368-72.
334. Wiese G, Ballowitz L: Dose-response relationship of phototherapy for neonatal hyperbilirubinemia, ‘NT 3 BIOL RES PREGNANCY, 1982; 3(1):1-2.
335. Sharma SK, Sood SC, Sharma A, Lall JC: Double vs. single surface phototherapy in neonatal hyperbilirubinemia, INDIAN PEDIATR, 1985 Mar; 22(3):235-9.
336. Mims L. Estrads M, Gooden D. et al: Phototherapy for neonatal hyperbilirubinemia – a dose:response relationship. J PEDIATR, 1973 Oct; 83(4):658-62.
337. Benernan R, Hais D: Summary of a symposium on phototherapy for hyperbilirubinemia. 3 PEDIATR. 1969 Oct; 75(4):718-26.
338. Granati B, Largajolli 0, Rubaltelli FF, Ct al: Efficacy and safety of the integral: phototherapy for neonatal hyperbilirubinemia. Results of a follow-up at 6 years of age. CLIN PEDIATR
(PHILA), 19%4 Sep; 23(9):483-6.
339. Siason TR: Measurements and monitoring of phototherapy in newborn jaundice, MED INSTRUM, 1982 May-Jun; 16(3):157-9.
340. Yamauch Y, Kasa N, Yamanouch I: Is it necessary to change babies’ position during phototherapy?, EARLY HUM DEVEL, 1989 Dec; 20(3-4):221-7.
341. Vogl T: Phototherapy of neonatal hyperbilirubinemia: bilirubin in unexposed areas of the skin, 3 PEDIATR. 1974 Nov; 85(5):707-10.
342. Richena R: Phototherapy treatment times using a fiber-optic vs. a high-dose fluorescent device, unpublished. 1991.
343. Yogi T, Hegyi T, Hiatt M, Ct al: Intermittent phototherapy in the treatment of jaundice in the premature infant, 3 PEDIATR, 1978 Apr, 92(4):627-30.
344. Lsu S, Fung K: Serum bilirubin kinetics in intermittent phototherapy of physiological jaundice, ARCH DIS CHILD, 1984; 1984:892-4.
345. Scheidt P, Stemthal P, Anderson R, Ct al: Photodosimeter badge system, PEDIATRICS. 1985; Suppl:43741.
346. Yarnauch Y, Yarnanouch I: Transcutaneous bilirubinometry: serum bilirubin measurement using transcutaneous bilirubinometer, BIOL NEONATE, 1989; 56(5):257-62.
347. Ebbesen F: Determination of serum bilirubin concentration during phototherapy of newborns and in vitro: results compared by the direct spectrometric method and the diazo
method, CUN CIIEM, 1977; 23(4):695-9.
348. Brucher MC, MacMullen NJ: Neonatal jaundice in the borne: assessment with a noninvasive device, 3 GB GYN NEONAT NURS, 1987 Sep-Oct; 16(5):355-8.
349. Fetus and Newborn Committee, Canadian Pediatric Society: Use of phototherapy for neonatal hyperbilirubinemia, CAN MED ASSOC 3,1986 Jun 1; 134(ll):1237-45.
350. Katcher A: Phototherapy, 3 FAM PRAC, 1982; 14(6):1123-33.
351. Roeder B, Skovbroten B: Home phototherapy program, CARING, 1985 May; 92-4.
352. Smith V, Giacois 0: Phototherapy in neonatal jaundice, POSTGRAD MED, 1986 Feb 1; 79(2):223-30.
353. Eggert L, Poilary R, Folland D, Jung A: Home phototherapy treatment of neonatal jaundice, PEDIATRICS, 1985 Oct; 76(4):579-84.
354. Sister L, Brewer MF: Home vs. hospital phototherapy for term infants with hyperbilirubinemia: a comparative study, PEDIATRICS, 1984 Apr; 73(4):5l5-9.
355. Rogerson AG, Grossman ER, Gruber HS, Ct al: 14 years of experience with home phototherapy, CUN PED (PIHLA), 1986 Jun; 25(6):296-9.
356. Grabert BE, Wardwell C, Harburg SK: Home phototherapy. An alternative to prolonged hospitalization of the full term, well newborn, CLIN PED (PHILA), 1986 Jun; 25(6):291A.
357. Elander G, Lindberg T: Hospital routines in Infants with hyperbilirubinemia influences the duration of breast feeding, ACTA PEDIATR SCAND, 1986 Sep; 75(5):70S-12.
358. Shibley B: Now newborns can stay home for phototherapy, RN, 19g8 Feb; 51(2):69-71.
359. Committee on Fetus and Newborn. Am. Arad. of Pediatrics: Home phototherapy. PEDIATRICS, 1985 Jul; 76(1):136.
360. Ray Richens, RCP: A Home Phototherapy Primer, HOME HEALTH CARE DEALER, 1992 Jan-Feb.; 64-66.